QL Biopharm Presented Results from Phase 1c Clinical Study on its Novel Once-Monthly GLP-1RA ZT002 at EASD 2024

Beijing QL Biopharmaceutical Co., Ltd.

View original content:https://www.prnewswire.co.uk/news-releases/ql-biopharm-presented-results-from-phase-1c-clinical-study-on-its-novel-once-monthly-glp-1ra-zt002-at-easd-2024-302245487.html